Product Images Eraxis
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Eraxis NDC 0049-2242 by Roerig, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a text to indicate that the product is distributed by Roerig, which is a division of Pfizer Inc. based in New York, NY 10001.*
- Store Eraxis® single-dose vial in the refrigerator between 2°C - 8°C (36°F - 46°F). Do not freeze. - Reconstitute Eraxis® with 30 ml of sterile water for injection. Each mL contains 3.3 mg anidulafungin. - Further dilute the reconstituted solution with 0.9% Sodium Chloride Injection for IV infusion only. - Follow recommended dosage instructions provided by your healthcare provider or prescribing information. - After reconstitution, use the solution within 24 hours. Distributed by Roerig, a division of Pfizer Inc.*
This text provides information about a medication called Eraxis®, which is used for intravenous infusion. It contains anidulafungin and other ingredients. The text includes details on dosage, reconstitution process, storage instructions, and contact information for Premier Healthcare Alliance. It also mentions the importance of following prescribing information for proper use.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.